Back
Open Access

Introduction.

Session: New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients
Topic: Treatment
Speaker: Professor J. Butler (Dallas, US)
Organised by Charité IME, supported by Boehringer Ingelheim & Eli Lilly and Company Alliance in the form of an educational grant
Event: ESC Congress 2020

Congress Presentation

Add to my library

Like

About the speaker

Professor Javed Butler

Baylor Scott & White Health, Dallas (United States of America)
116 presentations
18 followers

4 more presentations in this session

EMPEROR-REDUCED Trial: main results.

Speaker: Doctor M. Packer (Dallas, US)

Access
Video
Like
Thumbnail

SGLT2 inhibitors in HFrEF, a meta-analytical approach.

Speaker: Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access
Video
Like
Thumbnail

Panel discussion

Speaker: Professor G. Filippatos (Athens, GR) Professor J. Butler (Dallas, US) Professor M. Packer (Dallas, US) Professor S. Anker (Berlin, DE) Professor F. Zannad (Vandoeuvre-Les-Nancy, FR)

Access
Video
Like
Thumbnail

Conclusion.

Speaker: Professor M. Packer (Dallas, US)

Access
Video
Like
Thumbnail

Access the full session

New evidence on sodium-glucose transport protein 2 inhibitors therapy in heart failure patients

Speakers: Professor J. Butler, Doctor M. Packer, Professor F. Zannad, Professor G. Filippatos, Professor J. Butler...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources